Antibodies with proteolytic activity against myelin basic protein have been identified and characterized in detail in a number of autoimmune diseases, including multiple sclerosis, systemic lupus erythematosus, as well as in autism and schizophrenia. This evidence concerns the gene MBP and schizophrenia.